The fluorescence polarization immunoassay (FPIA) developed by Abbott to diagnose intoxication with tncyclic antidepressants was adapted for therapeutic drug monitoring and validated with chromatographic methods to investigate its potential for this use. We compared serum concentrations of tricyclic antidepressants in vivo and in vitro obtained by FPIA with those by gas chromatography and HPLC. For amitriptyline, imipramine, clomipramine, and doxepin, the detection limit of the FPIA was 72, 71, 64, and 72 nmol/L (-20 gIL), respectively; that by gas chromatography was 18, 18, and 16 nmol/L (-5 g/L) for amitnptyline, imipramine and clomipramine, respectively; with HPLC the lower limit of detection for doxepin was 36 nmol/L (10 g/L). The intra-and interassay CVs ranged from 3% to 6%. In patients being treated with amitriptyline, imipramine, clomipramine, and doxepin, at steady-state the correlation coefficients between FPIA and GCIHPLC results for split samples were 0.95, 0.92, 0.90 and 0.70, respectively. However, the slopes were close to unityonly for amitriptylineand doxepin, being 0.6 for imipramine and 1.9 for clomipramine.
we also analyzed our own internal quality-control samples, which contained concentrations as low as 10 .i.gfL.
To test the cross-reactivity of various drugs, we prepared stock solutions (1.0 g/L) of them in aqueous 1 g/L ascorbic acid in water. We diluted the stock solutions with serum from healthy subjects to obtain concentrations ranging from 10 to 1000 g/L. The amount of ascorbic acid in the final volume was <100 pgfL.
The intra-and interassay CVs for assays of the internal quality-control samples from the manufacturer were 4.2% and 4.7%, respectively.
In contrast, a check of the photometric integrity of the FPIA instrument over 4 years gave CVs for intensity and polarization of 2.3% and 0.5%, respectively.
During this same period the interassay
CVs for imiprainine-containing serum sampies stored in multiple aliquots at -20#{176}C were 9%, 7%, and 6% at concentrations of 100,200, and 500 jgIL (357, 714, and 1786 nmoIIL), respectively.
GLC quantification of serum amitriptyline, imipramine, and clomipramine.
GLC determination of the drugs was done as described earlier (14). In brief, we mixed the serum with an equal volume of 0.25 mol/L NaOH, extracted 2.0 mL of the alkalinized serum with 8 mL of n-heptane:isoamyl alcohol (98.5:1.5 by vol), reextracted the antidepressants from the organic phase into 1.2 mL of 0.1 mol/L HC1, and then added 1.0 mL of 1.0 mol/L sodium bicarbonate, pH 9.4, and reextracted the mixture into 0.1 mL of toluene:isoamyl alcohol (85:15 by vol). We injected 3 jL of this extract into GLC capillary columns and detected the drugs with a thermoiomc-(NPD) detector (Model 5880; Hewlett-Packard, Palo Alto, CA) (14). The data were analyzed with respect to amitriptyilne and nortriptyhne, imipramine and desipramine, and clomipramine and desmethylciomipramine.
The lower limit of detection with the zero calibrator was 5 pgfL (-17 nmolIL). The intra-and interassay CVs were 2.5-6.3% and 3.1-6.5%, respectively.
The external quality control, carried out with an unknown specimen obtained from Heathcontrol (Cardiff, UK), showed that all values analyzed during the time of these investigations were within the 95% confidence limits with respect to amitriptyline, nortriptyline, imipramine, and desipramine. An external quality control was not available for clomipramine. The internal quality control was done with 40 and 100 gfL doxepin (143 and 358 nmol/L) or desmethyldoxepin (151 and 377 nmol/L). The respective intra-and interassay CVs were 3% and 4% for doxepin and 5% and 6% for desmethyldoxepin.
This HPLC method for estimating serum doxepin and desmethyldoxepin concentrations was validated by external quality control with MTAKcontrol samples (TBM-TUX; MTAK-Laboratories, Canyon Country, CA) containing doxepin at 40 and 100 g1L; the concentrations observed were within the 95% confidence limit.
Statistics. All estimations were carried out in duplicate, unless otherwise mentioned. Linear regression analysis was performed to determine Pearson's r-value.
Results
Cross-reactivity.
We investigated the possibility of cross-reactivity of tricydic antidepressants and other drugs with the FPIA rabbit anti-tricycic antidepressant antibody and tracer. Amitriptyline, dosulepine, desipramine, and nortriptyline showed cross-reactivities ranging from 74% to 100%, compared with iinipramine (Table 1). Clomiprainune, doxepin, and opipramol showed less cross-reactivities; however, they were similar across the concentration range of 50-1000 mg/L (120-3600 Analyte stability.
To investigate the stability of the tricycic antidepres8ants
in patients' serum stored at -25#{176}C, we analyzed these samples by FPIA before and after 3-6 months' storage. The results indicated reasonable stability (r >0.96, slope >0.97, n = 45).
Assaying the concentrations of the tricycic antidepressants in sera kept for 7 days at 20-23#{176}C or at 4#{176}C yielded CVs of 2% and 3%, respectively.
The slope of the data for day 1 vs day 7 was close to unity, indicating that the serum concentrations of the drugs were stable at these temperatures for 1 week.
Intermethod comparison.
The drug concentrations of all serum samples were above the detection limit of the FPIA, GLC, or HPLC.
The correlation between the sum of the concentrations of amnitriptyline plus the active metabolite nortriptyline obtained by GLC vs the total antidepressant immunoreactivity determined by the FPIA was r = 0.95 (Fig. 1A, Table 2 ). The concentrations obtained by the FPIA were 19% higher than by GLC. The proportion of the active metabolite nortriptyline in relation to the sum of amitriptyline plus nortriptyline concentrations obtained by GLC was constant up to 800 nmol/L (288 pg/L). Beyond this concentration, the proportion of the active metaboite varied between 20% and 70% (data not shown).
The data on imipramine and desipramine showed a satisfactory correlation between the immunoreactivity estimated by FPIA and the sum of imipramine and desipramine determined by GLC (Fig. 1B, Table 2 ). However, the apparent concentrations by the FPIA were 36% higher than the sum of both compounds obtained by GLC. About two-thirds of the active drug was the metabolite desipramine, as may be inferred from the GLC results.
The correlation between the immunoreactivity (FPIA) of clomipramine and desmethyiclomipramine, and the sum of both compounds estimated by GLC, was r = 0.90, with a slope of 1.92 (Fig. 1C, Table 2 ). Desmethylclomipramine accounted for -71% of the sum of parent compound plus metabolite.
The HPLC data on the concentration of doxepin (Eand Z-isomers) plus desmethyldoxepin (E-and Z-isomers) correlated well with the corresponding immunereactivity estimated with the FPIA, the slope being close to unity (Fig. 1D, Table 2 ). The proportion of desmethyldoxepin with respect to parent compound plus metabolite was 48%.
Discussion
The introduction of therapeutic drug monitoring of antidepressants into the clinical setting was recommended to improve care of patients (1,3, 16-21) . We are currently examining in our psychiatric clinic the benefits of routine antidepressant drug monitoring in blood as an additional guideline to optimize drug therapy. To be able to report the serum concentrations of antidepressanta twice weekly, we adapted an immunological method, the FPIA, which was originally developed to detect toxic serum concentrations of these drugs. To validate this approach, we compared the serum concentrations measured by the FPIA with those of chromatographic methods.
The cross-reactivities of amitriptyline, imipramine, nortriptyline, and desipramine with the antibody and the tracer from the Abbott TDx procedure were close to 100%. The in vitro experiments indicated no interference between the parent compound and metabolite (data not shown); their concentrations appeared to be additive, and the antibody did not distinguish between the tertiary amino parent compound and the secondary amino metabolites.
The low intra-and interassay CVs of the FPIA (3-6%) permit longitudinal investigations. The results of the FPLA correlated well with those by GLC and HPLC for amitriptyline, imipramine, clomipramine, and doxepin. All intercepts of the correlation curves passed close to the origin. However, the slopes of the correlation analysis between methods were close to unity only for amitriptyline and doxepin. Because the cross-reactivity of clomipramine ranged from 40% to 60% and because the proportions of parent compound and metabolite were similar throughout the concentration range tested, the concentrations measured by GLC were twice those by FPIA (i.e., the correlation slope was 1.92). Over the entire concentration range, the serum concentrations of imipramine obtained by FPLA were 40% lower than those by GLC. This discrepancy was not due to the presence of the N-desmethylated metabolite, however, which showed a constant proportion of 62% to 72% ( The skillful technical assistance of C. Chapuis (Lausanne) is gratefully acknowledged.
The low detection

